Results 31 to 40 of about 713,845 (330)

Comboridity of chronic obstructive pulmonary disease and cardiovascular diseases: general factors, pathophysiological mechanisms and clinical significance [PDF]

Клиническая практика, 2020
Currently, the comorbidity (combination) of chronic obstructive pulmonary disease (COPD) and cardiovascular diseases (CVD) is an important problem for the health care. This is due to the high prevalence and continuing growth of these pathologies. CVD and
A. M. Chaulin, Yu. V. Grigoryeva, D. V. Duplyakov   +2 more
doaj   +1 more source

Biosensors for cardiac biomarkers detection: a review [PDF]

, 2012
The cardiovascular disease (CVD) is considered as a major threat to global health. Therefore, there is a growing demand for a range of portable, rapid and low cost biosensing devices for the detection of CVD.
Gurbuz, Yasar, Gürbüz, Yaşar, Kolkar Mohammed, Javed Hussain Niazi, Qureshi, Anjum   +3 more
core   +1 more source

CONCOMITANT DISEASES AND RISK FACTORS FOR THEIR DEVELOPMENT IN PATIENTS WITH HIV INFECTION OLDER THAN 40 YEARS

Журнал инфектологии, 2017
Objective: Evaluation of CVD and their risk factors in Russian 40+ HIV-infected patients is a key objective of the study. Materials and Methods: A retrospective analysis of 1872 medical records of 40+ HIV-infected patients from 12 regions of Russia on ...
D. A. Gusev, S. A. Buzunova, A. A. Yakovlev, V. B. Musatov, L. V. Glyzhina, S. A. Bykov, E. A. Strebkova, F. I. Nagimova, T. N. Bulatova, O. N. Kononchuk, R. G. Yapparov, S. V. Zajcev, V. N. Zapol’skaja, O. E. Chernova, Yu. K. Plotnikova, V. Yu. Rozenberg, E. I Mironova, M. G. Katjagina   +17 more
doaj   +1 more source

Gender-specific changes in quality of life following cardiovascular disease: a prospective study [PDF]

, 2002
Gender-specific changes in Quality of Life (QoL) following cardiovascular disease (CVD) were studied in 208 patients to determine whether gender-related differences in postmorbid QoL result from differences in disease severity, premorbid QoL, or ...
Kempen, G.I., Ormel, J., Ranchor, A.V., Sanderman, R., van Jaarsveld, C.H., van Veldhuisen, D.J.   +5 more
core   +2 more sources

Health care and hospitalisation costs of cardiovascular disease (CVD) in Thailand [PDF]

, 2019
Background: Cardiovascular disease (CVD) has become a leading cause of death and disability in Thailand due to the unhealthy lifestyle of the populace; triggering high risk of exposure to CVD, increase in the number of hospital admissions year on year.
Collins, Karen, IInthawong, Rungkarn, Ismail, Mubarak, Khatab, Khaled, Raheem, M, Whitfield, Malcolm   +5 more
core   +1 more source

Reducing weight and increasing physical activity in people at high risk of cardiovascular disease: a randomised controlled trial comparing the effectiveness of enhanced motivational interviewing intervention with usual care. [PDF]

, 2020
OBJECTIVE: The epidemic of obesity is contributing to the increasing prevalence of people at high risk of cardiovascular disease (CVD), negating the medical advances in reducing CVD mortality.
Ashworth, M, Bayley, A, Britneff, E, Cook, DG, Greenough, A, Ismail, K, McCrone, P, Ridge, K, Rundle, J, Stahl, D, Stewart, K, Treasure, J, Twist, K, Whincup, P, Winkley, K   +14 more
core   +1 more source

Influence of the oral status on cardiovascular diseases in an older Italian population [PDF]

, 2018
Oral diseases have been adversely associated with cardiovascular diseases (CVD), which are also the most frequent cause of death in older population. The aim of this study was to investigate the association among oral status indexes and CVD in patients
Basili, Stefania, Dan Trifan, Pompiliu, De Angelis, Francesca, Di Carlo, Stefano, FRATTO, Giovanni, Manzon, Licia   +5 more
core   +1 more source

Predictive value of coronary artery calcium score in cardiovascular disease

Frontiers in Bioscience-Elite, 2020
We investigated coronary heart disease (CHD) and cardiovascular disease (CVD) event rates in a diverse population with a coronary artery calcium score (CACS) of 0 and the role of CACS in the detection of subclinical noncalcified atherosclerotic plaque. A
Shurong Liu, Xue Zheng, Jiahuan Xu, Xinhua Wang, ,Yuzhen Zhang, Bin Lv, Liang Zheng, Kai Sun   +7 more
doaj   +1 more source

Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. [PDF]

, 2015
Apolipoprotein L1 gene (APOL1) G1 and G2 coding variants are strongly associated with chronic kidney disease (CKD) in African Americans (AAs). Here APOL1 association was tested with baseline estimated glomerular filtration rate (eGFR), urine albumin ...
Bild, Diane E, Divers, Jasmin, Freedman, Barry I, Hawfield, Amret T, Kaysen, George A, Kimmel, Paul L, Langefeld, Carl D, Pajewski, Nicholas M, Raj, Dominic S, Reboussin, David M, Ricardo, Ana C, Rocco, Michael V, Sedor, John R, Systolic Blood Pressure Intervention Trial (SPRINT), Wright, Jackson T   +14 more
core   +1 more source

CVD 908, CVD 908-htrA, and CVD 909 Live Oral Typhoid Vaccines: A Logical Progression [PDF]

Clinical Infectious Diseases, 2007
Typhoid fever remains an important public health problem in many parts of the world. Despite the availability of oral Ty21a (Vivotif; Berna Biotech) and parenteral Vi polysaccharide vaccine (Typhim Vi; Aventis Pasteur), improved typhoid fever vaccines have been sought.
Carol O, Tacket, Myron M, Levine
openaire   +2 more sources